162 related articles for article (PubMed ID: 12857896)
1. Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4.
Potvin DM; Metzger DW; Lee WT; Collins DN; Ramsingh AI
J Virol; 2003 Aug; 77(15):8272-9. PubMed ID: 12857896
[TBL] [Abstract][Full Text] [Related]
2. Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon.
Serreze DV; Wasserfall C; Ottendorfer EW; Stalvey M; Pierce MA; Gauntt C; O'Donnell B; Flanagan JB; Campbell-Thompson M; Ellis TM; Atkinson MA
J Virol; 2005 Jan; 79(2):1045-52. PubMed ID: 15613333
[TBL] [Abstract][Full Text] [Related]
3. Umifenovir Epigenetically Targets the
Zhang S; Xue X; Qiao S; Jia L; Wen X; Wang Y; Wang C; Li H; Cui J
Microbiol Spectr; 2023 Feb; 11(1):e0424822. PubMed ID: 36541788
[TBL] [Abstract][Full Text] [Related]
4. IL-10 is pathogenic during the development of coxsackievirus B4-induced chronic pancreatitis.
Gu R; Shampang A; Reilly A; Fisher D; Glass W; Ramsingh AI
Virology; 2009 Dec; 395(1):77-86. PubMed ID: 19800092
[TBL] [Abstract][Full Text] [Related]
5. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H
Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart.
Fairweather D; Frisancho-Kiss S; Yusung SA; Barrett MA; Davis SE; Gatewood SJ; Njoku DB; Rose NR
Am J Pathol; 2004 Dec; 165(6):1883-94. PubMed ID: 15579433
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory rather than infectious insults play a role in exocrine tissue damage in a mouse model for coxsackievirus B4-induced pancreatitis.
De Palma AM; Thibaut HJ; Li S; Van Aelst I; Dillen C; Swinnen M; Verbeken E; Neyts J; Opdenakker G
J Pathol; 2009 Apr; 217(5):633-41. PubMed ID: 19142976
[TBL] [Abstract][Full Text] [Related]
8. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.
Henke A; Zell R; Ehrlich G; Stelzner A
J Virol; 2001 Sep; 75(17):8187-94. PubMed ID: 11483764
[TBL] [Abstract][Full Text] [Related]
9. Strains of coxsackie virus B4 differed in their ability to induce acute pancreatitis and the responses were negatively correlated to glucose tolerance.
Hindersson M; Orn A; Harris RA; Frisk G
Arch Virol; 2004 Oct; 149(10):1985-2000. PubMed ID: 15669109
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of the pancreas after oral infection of genetically diverse mice with coxsackievirus B4-E2.
Precechtelova J; Borsanyiova M; Stipalova D; Sarmirova S; Gomolcak P; Berakova K; Bopegamage S
Arch Virol; 2015 Jan; 160(1):103-15. PubMed ID: 25293347
[TBL] [Abstract][Full Text] [Related]
11. Coxsackievirus B4 infection of the mouse pancreas: the role of natural killer cells in the control of virus replication and resistance to infection.
Vella C; Festenstein H
J Gen Virol; 1992 Jun; 73 ( Pt 6)():1379-86. PubMed ID: 1607859
[TBL] [Abstract][Full Text] [Related]
12. Using IFN-gamma as a biomarker for detecting exposure to viral pathogens.
Li L; Dufour AP
Curr Microbiol; 2008 Jan; 56(1):84-8. PubMed ID: 17926092
[TBL] [Abstract][Full Text] [Related]
13. Coxsackievirus B4 sewage-isolate induces pancreatitis after oral infection of mice.
Benkoova B; Pospisilova M; Kramna L; Kissova R; Berakova K; Klement C; Cinek O; Bopegamage S
FEMS Microbiol Lett; 2021 Aug; 368(15):. PubMed ID: 34297106
[TBL] [Abstract][Full Text] [Related]
14. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
Scharton-Kersten TM; Wynn TA; Denkers EY; Bala S; Grunvald E; Hieny S; Gazzinelli RT; Sher A
J Immunol; 1996 Nov; 157(9):4045-54. PubMed ID: 8892638
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses.
Gu R; Shampang A; Nashar T; Patil M; Fuller DH; Ramsingh AI
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824074
[TBL] [Abstract][Full Text] [Related]
16. Yakammaoto inhibited human coxsackievirus B4 (CVB4)-induced airway and renal tubular injuries by preventing viral attachment, internalization, and replication.
Yen MH; Lee JJ; Yeh CF; Wang KC; Chiang YW; Chiang LC; Chang JS
J Ethnopharmacol; 2014 Feb; 151(3):1056-1063. PubMed ID: 24361333
[TBL] [Abstract][Full Text] [Related]
17. A synergistic interferon-gamma production is induced by mouse hepatitis virus in interleukin-12 (IL-12)/IL-18-activated natural killer cells and modulated by carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1a receptor.
Jacques A; Bleau C; Turbide C; Beauchemin N; Lamontagne L
Immunology; 2009 Sep; 128(1 Suppl):e551-61. PubMed ID: 19740316
[TBL] [Abstract][Full Text] [Related]
18. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
Orange JS; Wang B; Terhorst C; Biron CA
J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
[TBL] [Abstract][Full Text] [Related]
19. Progression or resolution of coxsackievirus B4-induced pancreatitis: a genomic analysis.
Ostrowski SE; Reilly AA; Collins DN; Ramsingh AI
J Virol; 2004 Aug; 78(15):8229-37. PubMed ID: 15254194
[TBL] [Abstract][Full Text] [Related]
20. Direct interferon-gamma-mediated protection caused by a recombinant coxsackievirus B3.
Henke A; Zell R; Martin U; Stelzner A
Virology; 2003 Oct; 315(2):335-44. PubMed ID: 14585336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
